-
公开(公告)号:US10711274B2
公开(公告)日:2020-07-14
申请号:US16364126
申请日:2019-03-25
IPC分类号: C07H21/04 , C12N15/113 , C12N15/11 , C12N15/86
摘要: The invention relates to inhibitory nucleic acids and rAAV-based compositions, methods and kits useful for treating Amyotrophic Lateral Sclerosis.
-
公开(公告)号:US20230295629A1
公开(公告)日:2023-09-21
申请号:US18178206
申请日:2023-03-03
IPC分类号: C12N15/113
CPC分类号: C12N15/113 , C12N2310/11 , C12N2310/3341 , C12N2310/321 , C12N2310/3231 , C12N2310/315
摘要: The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
-
公开(公告)号:US10851375B2
公开(公告)日:2020-12-01
申请号:US16403948
申请日:2019-05-06
IPC分类号: C07H21/04 , C12N15/113 , C12N15/11 , C12N15/86
摘要: The invention relates to inhibitory nucleic acids and rAAV-based compositions, methods and kits useful for treating Amyotrophic Lateral Sclerosis.
-
公开(公告)号:US11629347B2
公开(公告)日:2023-04-18
申请号:US16868237
申请日:2020-05-06
IPC分类号: C12N15/113
摘要: The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
-
公开(公告)号:US10954518B2
公开(公告)日:2021-03-23
申请号:US16295621
申请日:2019-03-07
IPC分类号: C07H21/04 , C12N15/113 , C12N15/11 , C12N15/86
摘要: The invention relates to inhibitory nucleic acids and rAAV-based compositions, methods and kits useful for treating Amyotrophic Lateral Sclerosis.
-
公开(公告)号:US10280418B2
公开(公告)日:2019-05-07
申请号:US15126688
申请日:2015-03-18
IPC分类号: C07H21/04 , C12N15/113 , C12N15/11 , C12N15/86
摘要: The invention relates to inhibitory nucleic acids and rAAV-based compositions, methods and kits useful for treating Amyotrophic Lateral Sclerosis.
-
公开(公告)号:US10258668B2
公开(公告)日:2019-04-16
申请号:US15023044
申请日:2014-03-12
申请人: THE GENERAL HOSPITAL CORPORATION , MASSACHUSETTS EYE AND EAR INFIRMARY , UNIVERSITY OF MASSACHUSETTS
发明人: Patricia K. Donahoe , Demetrios Vavvas , David Pepin , Mien Van Hoang , Robert H. Brown, Jr. , Guangping Gao
IPC分类号: A61K38/22 , C07K16/26 , C07K14/575 , A61K48/00 , C07K14/765 , C12N7/00 , C12N15/86
摘要: The present invention relates to methods to treat a neurodegenerative disease or disorder, e.g., a motor neuron disease in a subject, whereby the subject is administered a recombinant human Mullerian Inhibiting Substance (MIS) protein as disclosed herein, wherein the recombinant human MIS protein comprises a modified Kex cleavage site for increased cleavage. The recombinant human MIS protein can be produced from a pre-proprotein comprising a non-MIS leader sequence or a functional fragment thereof in place of the MIS leader sequence.
-
公开(公告)号:US20240011027A1
公开(公告)日:2024-01-11
申请号:US17914706
申请日:2021-03-25
IPC分类号: C12N15/113 , A61P25/28
CPC分类号: C12N15/113 , A61P25/28 , C12N2310/11 , C12N2310/316 , C12N2310/3231 , C12N2320/33
摘要: The disclosure relates to compositions and methods for treating a disease or condition associated with a TDP-pathology or a decline in TDP-43 functionality in neuronal cells in a subject, and for identifying candidate agents to suppress or prevent inclusion of an abortive or altered STMN2 RNA sequence.
-
公开(公告)号:US11827886B2
公开(公告)日:2023-11-28
申请号:US16872448
申请日:2020-05-12
IPC分类号: C12N15/113 , C12Q1/6883 , C07K16/18 , C12N15/86 , G01N33/68
CPC分类号: C12N15/1138 , C07K16/18 , C12N15/86 , C12Q1/6883 , G01N33/6872 , C07K2317/34 , C12N2310/11 , C12N2320/33 , C12N2320/53 , C12N2750/14143 , C12Q2600/156 , G01N2333/705 , G01N2800/2878
摘要: Aspects of the disclosure relate to methods of altering RNA splicing in a subject. In some embodiments, methods are provided for correcting splicing in a cell that contains a DYSF gene having a mutation that results in defective splicing.
-
公开(公告)号:US11760999B2
公开(公告)日:2023-09-19
申请号:US17174452
申请日:2021-02-12
IPC分类号: C07H21/04 , C12N15/113 , C12N15/11 , C12N15/86
CPC分类号: C12N15/113 , C12N15/111 , C12N15/1137 , C12N15/86 , C12Y115/01001 , C12N2310/14 , C12N2310/141 , C12N2320/32 , C12N2330/51 , C12N2750/14143
摘要: The invention relates to inhibitory nucleic acids and rAAV-based compositions, methods and kits useful for treating Amyotrophic Lateral Sclerosis.
-
-
-
-
-
-
-
-
-